Toggle Main Menu Toggle Search

Open Access padlockePrints

Tau acts as an independent genetic risk factor in pathologically proven PD

Lookup NU author(s): Professor David Burn, Professor Patrick Chinnery

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

MAPT has been repeatedly linked with Parkinson's disease (PD) in association studies. Although tau deposition may be seen in PD, its relevance to the pathogenesis of the condition remains unclear. The presence of tau-positive inclusions is, however, the defining feature of progressive supranuclear palsy (PSP), which may often be clinically misdiagnosed as idiopathic PD. On a genetic level, variants in MAPT are the strongest risk factor for PSP. These facts raise the question whether the MAPT association in PD results from contamination with unrecognized cases of PSP. Using only neuropathologically proven PD, we show that the MAPT association remains and is independent of the PSP Association. (C) 2012 Elsevier Inc. All rights reserved.


Publication metadata

Author(s): Charlesworth G, Gandhi S, Bras JM, Barker RA, Burn DJ, Chinnery PF, Gentleman SM, Guerreiro R, Hardy J, Holton JL, Lees A, Morrison K, Sheerin UM, Williams N, Morris H, Revesz T, Wood NW

Publication type: Article

Publication status: Published

Journal: Neurobiology of Aging

Year: 2012

Volume: 33

Issue: 4

Pages: 838.e7

Print publication date: 04/01/2012

ISSN (print): 0197-4580

ISSN (electronic): 1558-1497

Publisher: Elsevier Inc.

URL: http://dx.doi.org/10.1016/j.neurobiolaging.2011.11.001

DOI: 10.1016/j.neurobiolaging.2011.11.001


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
WT089698/Z/09/ZWellcome Trust Disease Centre
WT089698Wellcome Trust/Medical Research Council
Department of Health's National Institute for Health Research Biomedical Research Centres
083948/Z/07/ZWellcome Trust
8047Parkinson's UK
G0700943Medical Research Council
J-0804Parkinson's UK

Share